Journal article
Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir
Journal of medicinal chemistry, Vol.63(6), pp.3120-3130
03/26/2020
DOI: 10.1021/acs.jmedchem.9b01900
PMCID: PMC8827112
PMID: 32069052
Abstract
Vaccination is the most prevalent prophylactic means for controlling seasonal influenza infections. However, an effective vaccine usually takes at least 6 months to develop for the circulating strains. Therefore, new therapeutic options are needed for the acute treatment of influenza infections to control this virus and prevent epidemics/pandemics from developing. We have discovered fast-acting, orally bioavailable acylated 4-aminopiperidines with an effective mechanism of action targeting viral hemagglutinin (HA). Our data show that these compounds are potent entry inhibitors of influenza A viruses. We present docking studies that suggest an HA binding site for these inhibitors on H5N1. Compound 16 displayed a significant decrease of viral titer when evaluated in the infectious assays with influenza virus H1N1 (A/Puerto Rico/8/1934) or H5N1 (A/Vietnam/1203/2004) strains and the oseltamivir-resistant strain with the most common H274Y mutation. In addition, compound 16 showed significant synergistic activity with oseltamivir in vitro.
Details
- Title: Subtitle
- Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir
- Creators
- Irina N. Gaisina - University of Illinois ChicagoNorton P. Peet - Chicago BioSolutions, Inc., 2242 West Harrison Street, Chicago, Illinois 60612, United States.Han Cheng - University of Illinois ChicagoPing Li - Shandong University of Traditional Chinese MedicineRuikun Du - Shandong University of Traditional Chinese MedicineQinghua Cui - Shandong University of Traditional Chinese MedicineKevin Furlong - University of ChicagoBalaji Manicassamy - University of IowaMichael Caffrey - University of Illinois ChicagoGregory R. J. Thatcher - University of Illinois ChicagoLijun Rong - University of Illinois Chicago
- Resource Type
- Journal article
- Publication Details
- Journal of medicinal chemistry, Vol.63(6), pp.3120-3130
- DOI
- 10.1021/acs.jmedchem.9b01900
- PMID
- 32069052
- PMCID
- PMC8827112
- NLM abbreviation
- J Med Chem
- ISSN
- 0022-2623
- eISSN
- 1520-4804
- Publisher
- Amer Chemical Soc
- Number of pages
- 11
- Grant note
- AI127031 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
- Language
- English
- Date published
- 03/26/2020
- Academic Unit
- Microbiology and Immunology
- Record Identifier
- 9984297439302771
Metrics
41 Record Views